Autoimmune serology testing in clinical practice: an updated roadmap for the diagnosis of autoimmune hepatitis
GN Dalekos, NK Gatselis - European Journal of Internal Medicine, 2023 - Elsevier
Diagnosis of autoimmune hepatitis (AIH) is in most cases challenging for clinicians as there
is not a single specific laboratory or histological marker to diagnose or exclude the presence …
is not a single specific laboratory or histological marker to diagnose or exclude the presence …
The Asian Pacific Association for the Study of the Liver clinical practice guidance: the diagnosis and management of patients with autoimmune hepatitis
G Wang, A Tanaka, H Zhao, J Jia, X Ma… - Hepatology …, 2021 - Springer
Guiqiang Wang1, 18· Atsushi Tanaka2· Hong Zhao1, 1 8· Jidong Jia3· Xiong Ma4· Kenichi
Harada5· Fu‑Sheng Wang6· Lai Wei7· Qixia Wang4· Ying Sun6· Yuan Hong1· Huiying …
Harada5· Fu‑Sheng Wang6· Lai Wei7· Qixia Wang4· Ying Sun6· Yuan Hong1· Huiying …
Autoimmune hepatitis in patients aged 70 years or older: disease characteristics, treatment response and outcome
GN Dalekos, K Azariadis, V Lygoura… - Liver …, 2021 - Wiley Online Library
Abstract Background & Aims Autoimmune hepatitis (AIH) affects both sexes and all age
groups. However, very few studies have focused specifically on the characteristics and …
groups. However, very few studies have focused specifically on the characteristics and …
[PDF][PDF] Diagnosis and treatment of autoimmune hepatitis: questions, answers, and illustrative cases: endorsed by autoimmune liver diseases special interest group …
E Ozaslan, F Günşar, A Çiftçibaşi Örmeci… - Turk J …, 2023 - turkjgastroenterol.org
Autoimmune hepatitis (AIH) is a rare, immune-mediated liver disease. It has a
heterogeneous nature with varied clinical presentations. The management of patients with …
heterogeneous nature with varied clinical presentations. The management of patients with …
[HTML][HTML] PNPLA3 I148M genetic variant in autoimmune hepatitis characterises advanced disease at diagnosis and reduced survival free of cirrhotic events and liver …
Background Autoimmune hepatitis (AIH) is a relatively rare autoimmune disease with a
strong genetic background. The patatin-like phospholipase domain-containing protein 3 …
strong genetic background. The patatin-like phospholipase domain-containing protein 3 …
[HTML][HTML] Programmed cell death-1 rs11568821 and interleukin-28B rs12979860 polymorphisms in autoimmune hepatitis
Background Autoimmune hepatitis (AIH) is a relatively rare chronic liver disease of unknown
etiology. The genetic background affects susceptibility, clinical phenotype, and prognosis …
etiology. The genetic background affects susceptibility, clinical phenotype, and prognosis …
Acute severe autoimmune hepatitis–timing for steroids and role of other immunosuppressive agents
R Liberal, G Macedo - Journal of Hepatology, 2021 - journal-of-hepatology.eu
We read with great interest the manuscript by de Martin et al., 1 reporting early predictive
factors for a non-response to corticosteroid therapy in acute severe autoimmune hepatitis …
factors for a non-response to corticosteroid therapy in acute severe autoimmune hepatitis …
Reply to:“Small esophageal varices in compensated cirrhosis patients: To treat or not to treat?”
H Wang, B Wen, J Chen - Journal of Hepatology, 2021 - journal-of-hepatology.eu
Unlike many other prospective studies, our cohort mainly comprises patients with virally
suppressed HBV-related cirrhosis, which is more common in Asian countries. Of the 341 …
suppressed HBV-related cirrhosis, which is more common in Asian countries. Of the 341 …
Reply to:“Acute severe autoimmune hepatitis–timing for steroids and role of other immunosuppressive agents”
E De Martin, JC Duclos-Vallée - Journal of Hepatology, 2021 - journal-of-hepatology.eu
We would like to thank Liberal et al. for their interest in our recently published paper 1 and
their very interesting comments. 2 Concerning the modalities for corticosteroid …
their very interesting comments. 2 Concerning the modalities for corticosteroid …